Cargando…

Should aspirin be used for prophylaxis of COVID-19-induced coagulopathy?

Detalles Bibliográficos
Autores principales: Mohamed-Hussein, Aliae A.R., Aly, Karim M.E., Ibrahim, Mohamed-Eltaher A.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834233/
https://www.ncbi.nlm.nih.gov/pubmed/32531536
http://dx.doi.org/10.1016/j.mehy.2020.109975
_version_ 1783642237483089920
author Mohamed-Hussein, Aliae A.R.
Aly, Karim M.E.
Ibrahim, Mohamed-Eltaher A.A.
author_facet Mohamed-Hussein, Aliae A.R.
Aly, Karim M.E.
Ibrahim, Mohamed-Eltaher A.A.
author_sort Mohamed-Hussein, Aliae A.R.
collection PubMed
description
format Online
Article
Text
id pubmed-7834233
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-78342332021-01-26 Should aspirin be used for prophylaxis of COVID-19-induced coagulopathy? Mohamed-Hussein, Aliae A.R. Aly, Karim M.E. Ibrahim, Mohamed-Eltaher A.A. Med Hypotheses Article Elsevier Ltd. 2020-11 2020-06-08 /pmc/articles/PMC7834233/ /pubmed/32531536 http://dx.doi.org/10.1016/j.mehy.2020.109975 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Mohamed-Hussein, Aliae A.R.
Aly, Karim M.E.
Ibrahim, Mohamed-Eltaher A.A.
Should aspirin be used for prophylaxis of COVID-19-induced coagulopathy?
title Should aspirin be used for prophylaxis of COVID-19-induced coagulopathy?
title_full Should aspirin be used for prophylaxis of COVID-19-induced coagulopathy?
title_fullStr Should aspirin be used for prophylaxis of COVID-19-induced coagulopathy?
title_full_unstemmed Should aspirin be used for prophylaxis of COVID-19-induced coagulopathy?
title_short Should aspirin be used for prophylaxis of COVID-19-induced coagulopathy?
title_sort should aspirin be used for prophylaxis of covid-19-induced coagulopathy?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834233/
https://www.ncbi.nlm.nih.gov/pubmed/32531536
http://dx.doi.org/10.1016/j.mehy.2020.109975
work_keys_str_mv AT mohamedhusseinaliaear shouldaspirinbeusedforprophylaxisofcovid19inducedcoagulopathy
AT alykarimme shouldaspirinbeusedforprophylaxisofcovid19inducedcoagulopathy
AT ibrahimmohamedeltaheraa shouldaspirinbeusedforprophylaxisofcovid19inducedcoagulopathy